IJPN  >> Vol. 6 No. 3 (August 2017)

    3D-TOF MRA序列筛查脑微出血在脑梗死出血性转化中的预警价值
    Cerebral Microbleeds Screening with Original Image of 3D-TOF MRA Sequences Predicting Hemorrhagic Transformation in the Patients with Cerebral Infarction

  • 全文下载: PDF(590KB) HTML   XML   PP.18-26   DOI: 10.12677/IJPN.2017.63004  
  • 下载量: 911  浏览量: 2,202   国家自然科学基金支持


于永鹏:青岛大学附属威海市中心医院神经内科,中心实验室脑病研究室,山东 威海;
刘丽君:青岛大学附属医院黄岛分院神经内科,山东 青岛

脑梗死脑微出血出血性转化三维时间飞跃法磁共振血管成像磁敏感加权成像Cerebral Infarction Cerebral Microbleeds Hemorrhagic Transformation 3D-TOF MRA SWI


目的:探讨三维时间飞跃法磁共振血管成像(Three dimensional time-of-flight magnetic resonance angiography, 3D-TOF MRA)原始图像评估脑梗死患者脑微出血(Cerebral microbleeds, CMBs)病灶的可行性,进一步探讨3D-TOF序列在预测脑梗死出血性转化中的应用价值。方法:选取192例脑梗死患者为研究对象,分别进行磁敏感加权成像(Susceptibility weighted imaging, SWI)和3D-TOF序列扫描,评估SWI及3D-TOF MRA原始轴位图像显示CMBs的优劣。观察脑梗死出血性转化在CT、T1WI、DWI、SWI及3D-TOF MRA序列原始图像中的影像学表现及CMBs的分布和信号特点,明确基于3D-TOF序列CMBs病灶数量分级与出血性转化的关系,探讨3D-TOF序列在预测脑梗死出血性转化中的应用价值。结果: 因影像学资料显示不清排除12例,实际纳入180例脑梗死患者,SWI共发现微出血病灶264个,CMBs数目分级:28例为轻度,8例为中度,4例为重度。3D-TOF MRA序列原始图像发现微出血病灶188个,其中24例为轻度,4例为中度,4例为重度。两种序列对微出血病灶的检出率比较差异有统计学意义(皮质和皮质下、丘脑、小脑,p < 0.05);两者对基底节和脑干的微出血病灶检出率差异无统计学意义(p < 0.05)。180例患者中,24例发生出血性转化(13.3%),T1WI、DWI、SWI及3D-TOF MRA序列检测出血性转化的敏感度分别为25.0%、62.5%、100%及83.3%。CMBs病灶数量与出血性转化的发生率呈正相关。结论:在缺乏SWI序列的情况下,3D-TOF MRA原始图像可有效显示CMBs病灶,可作为预测脑梗死发生出血性转化的有效手段之一。

Objective: To investigate the feasibility of the original image of the three-dimensional time of flight MR angiography (Three dimensional time-of-flight magnetic resonance angiography, 3D- TOF MRA) assessing cerebral microbleeds (CMBs) in the patients with cerebral infarction, and further investigate the application value of 3D-TOF sequence in predicting hemorrhagic transformation from cerebral infarction. Methods: 192 cases of patients with cerebral infarction were enrolled into this study, and susceptibility weighted imaging (SWI) and 3D-TOF sequence scanning were performed to assess the ability of SWI and original axial images of 3D-TOF MRA showing CMBs. We investigated the imaging signal distribution of hemorrhagic transformation with cerebral infarction in the original image of CT, T1WI, DWI, SWI and 3D-TOF MRA sequences and the characteristics of CMBs to clarify the relationship between the number grade of lesions and hemorrhagic transformation a clear sequence of CMBs based on 3D-TOF sequence, and explored the application value of 3D-TOF predicting hemorrhagic transformation with cerebral infarction. Results: 12 cases were excluded for the unclear imaging data. SWI found 264 lesions of CMBs among 180 cases with cerebral infarction. Classification of CMBs: 28 cases of mild, 8 cases of moderate, and 4 cases of severe. The original sequences of 3D-TOF MRA found 188 lesions of CMBs including 24 cases of mild, four cases of moderate, and four cases of severe. There was statistically significant difference in the CMBs lesions detection rate between these two sequences (cortical vs. subcortical, thalamus, cerebellum, p < 0.05). There was no significant difference in CMBs lesions detection rate in the basal ganglia and brainstem between them (p < 0.05). Among 180 patients, there were a total of 24 cases of hemorrhagic transformation (13.3%). The detection sensitivities of hemorrhagic transformation of T1WI, DWI, SWI and 3D-TOF MRA sequence were 25.0%, 62.5%, 100% and 83.3%. CMBs lesions number was positively correlated with the incidence of hemorrhagic transformation. Conclusion: In the absence of SWI sequence, the original image of 3D-TOF MRA sequence can effectively display CMBs lesions, which can be used as an effective means of predicting hemorrhagic transformation of cerebral infarction.

于永鹏, 刘丽君. 3D-TOF MRA序列筛查脑微出血在脑梗死出血性转化中的预警价值[J]. 国际神经精神科学杂志, 2017, 6(3): 18-26. https://doi.org/10.12677/IJPN.2017.63004


[1] 冯洁, 刘运海. 脑微出血研究进展[J]. 中国神经免疫学和神经病学杂志, 2012, 19(3): 157-160.
[2] Lindley, R.I., Wardlaw, J.M., Sandercock, P.A., et al. (2004) Frequency and Risk Factors for Spontaneous Hemorrhagic Transformation of Cerebral Infarction. Journal of Stroke and Cerebrovascular Diseases, 13, 235-246.
[3] Nighoghossian, N., Hermier, M., Adeleine, P., et al. (2002) Old Microbleeds Are a Potential Risk Factor for Cerebral Bleeding after Ischemic Stroke: A Gradient-Echo T2*-Weighted Brain MRI Study. Stroke, 33, 735-742.
[4] Derex, L., Nighoghossian, N., Hermier, M., et al. (2004) Thrombolysis for Ischemic Stroke in Patients with Old Microbleeds on Pretreatment MRI. Cerebrovascular Diseases, 17, 238-241.
[5] Lee, S.H., Bae, H.J., Yoon, B.W., et al. (2002) Low Concentration of Serum Total Cholesterol Is Associated with Multifocal Signal Loss Lesions on Gradient-Echo Magnetic Resonance Imaging: Analysis of Risk Factors for Multifocal Signal Loss Lesions. Stroke, 33, 2845-2849.
[6] Lee, S., Bae, H., Kwon, S., et al. (2004) Cerebralm Icrobleeds Are Regionally Associated with Intracerebral Hemorrhage. Neurology, 62, 72-76.
[7] Roob, G., Lechner, A., Schmidt, R., et al. (2000) Frequency and Location of Microbleeds in Patients with Primary Intracerebral Hemorrhage. Stroke, 31, 2665-2669.
[8] Ueno, H., Naka, H., Ohshita, T., et al. (2008) Association between Cerebral Microbleeds on T2 Weighted MR Images and Recurrent Hemorrhagic Stroke in Patients Treated with Warfarin Following Ischemic Stroke. American Journal of Neuroradiology, 29, 1483-1486.
[9] Werring, D.J., Frazer, D.W., Coward, L.J., et al. (2004) Cognitive Dysfunction in Patients with Cerebral Microbleeds on T2 Weighted Gradient-Echo MRI. Brain, 127, 2265-2275.
[10] Schrag, M. and Greer, D.M. (2014) Clinical Associations of Cerebral Microbleeds on Magnetic Resonance Neuroimaging. Journal of Stroke and Cerebrovascular Diseases, 23, 2489-2497.
[11] Wang, X., Wei, X.E., Li, M.H., et al. (2014) Microbleeds on Susceptibility-Weighted MRI in Depressive and Non- Depressive Patients after Mild Traumatic Brain Injury. Neurological Sciences, 35, 1533-1539.
[12] Gratz, P.P., El-Koussy, M., Hsieh, K., et al. (2014) Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients. Stroke, 45, 1684-1688.
[13] Patel, B., Lawrence, A.J., Chung, A.W., et al. (2013) Cerebral Microbleeds and Cognition in Patients with Symptomatic Small Vessel Disease. Stroke, 44, 356-361.
[14] Vernooij, M.W., van der Lugt, A., Ikram, M.A., et al. (2008) Prevalence and Risk Factors of Cerebral Microbleeds: The Rotterdam Scan Study. Neurology, 70, 1208-1214.
[15] Koennecke, H.C. (2006) Cerebral Microbleeds on MRI: Prevalence, Associations, and Potential Clinical Implications. Neurology, 66, 165-171.
[16] Dannenberg, S., Scheitz, J.F., Rozanski, M., et al. (2014) Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage after Intravenous Thrombolysis. Stroke, 45, 2900-2905.
[17] Wang, B.G., Yang, N., Lin, M. and Lu, B. (2014) Analysis of Risk Factors of Hemorrhagic Transformation after Acute Ischemic Stroke: Cerebral Microbleeds Do Not Correlate with Hemorrhagic Transformation. Cell Biochemistry and Biophysics, 70, 135-142.
[18] Charidimou, A., Kakar, P., Fox, Z., et al. (2013) Cerebral Microbleeds and the Risk of Intracerebral Haemorrhage after Thrombolysis for Acute Ischaemic Stroke: Systematic Review and Meta-Analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 84, 277-280.
[19] Akoudad, S., Ikram, M.A., Koudstaal, P.J., et al. (2013) Cerebral Microbleeds and the Risk of Mortality in the General Population. European Journal of Epidemiology, 28, 815-821.
[20] Hermier, M., Nighoghossian, N., Derex, L., et al. (2003) Hypointense Transcerebral Veins at T2*-Weighted MRI: A Marker of Hemorrhagic Transformation Risk in Patients Treated with Intravenous Tissue Plasminogen Activator. Journal of Cerebral Blood Flow & Metabolism, 23, 1362-1370.
[21] Loehrer, E., Ikram, M.A., Akoudad, S., et al. (2014) Apolipo-protein E Genotype Influences Spatial Distribution of Cerebral Microbleeds. Neurobiology of Aging, 35, 899-905.
[22] Lanfranconi, S., Franco, G., Borellini, L., et al. (2013) Genetics of Cerebral Hemorrhage and Microbleeds. Panminerva Medica, 55, 11-28.
[23] Fernandez-Cadenas, I., Alvarez Sabin, J., Molina, C.A., et al. (2006) ApoE Genotype Influences on Efficacy and Safety of Thrombolytic Treatment for Ischemic Stroke. Neurologia, 21, 176-180.
[24] Zhang, X., Cao, X., Xu, X., et al. (2015) Correlation between the -1562C/T Polymorphism in the Matrix Metalloproteinase-9 Gene and Hemorrhagic Transformation of Ischemic Stroke. Experimental and Therapeutic Medicine, 9, 1043-1047.
[25] Mallolas, J., Rodríguez, R., Gubern, C., et al. (2014) A Polymorphism in the Promoter Region of the Survivin Gene Is Related to Hemorrhagic Transformation in Patients with Acute Ischemic Stroke. NeuroMolecular Medicine, 16, 856- 861.
[26] Appelboom, G., Piazza, M., Bruce, S.S., et al. (2012) Variation in a Locus Linked to Platelet Aggregation Phenotype Predicts Intraparenchymal Hemorrhagic Volume. Neurological Research, 34, 232-237.
[27] Shoamanesh, A., Preis, S.R., Beiser, A.S., et al. (2015) Inflammatory Biomarkers, Cerebral Microbleeds, and Small Vessel Disease: Framingham Heart Study. Neurology, 84, 825-832.